President and Chief Executive Officer · Verona Pharma plc (VRNA)

David Zaccardelli

A named executive officer of Verona Pharma in every fiscal year CompBrief holds from FY2022 to FY2024. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2024

$19,456,473

Salary $873,015Stock awards $18,089,500

FY2023: $6,597,473

1st of 5 named executive officers at Verona Pharma by FY2024 total.

5 named officers on file for Verona Pharma, FY2024

David Zaccardelli’s pay file — $29

  • 3 fiscal years of pay, line by line
  • 2 equity grants, each cited to its filing
  • VRNA’s disclosed peer group of 18 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Verona Pharma’s whole pay program stands against its peers

  • Verona Pharma’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on VRNA→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed March 18, 2025 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get David Zaccardelli’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

David Zaccardelli compensation by year

Verona Pharma Summary Compensation Table · all 3 fiscal years held
In US dollars, as Verona Pharma reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024
Salary$524,842$819,568$873,015
Bonus$0$0$0
Stock awards$4,133,500$5,324,000$18,089,500
Option awards$0$0$0
Non-equity incentive$497,297$440,705$480,158
Pension and deferred compensation$0$0$0
All other$27,501$13,200$13,800
Total$5,183,140$6,597,473$19,456,473

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Verona Pharma plc DEF 14A filed March 18, 2025, accession 0001104659-25-025050, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Verona Pharma plc filed document, accession 0001104659-25-025050. Every figure is read from that document and cited to the page and table it appears in. Filed March 18, 2025.

$5.2M
$6.6M
$19.5M
FY22
FY23
FY24
SalaryNon-equity incentiveStock awardsAll other

Equity holdings

unvested awards at FY2024 year-end
TypeUnvested unitsValue at year-endExercise price
PSU300,000$13,932,000—
RSU225,000$10,449,000—
RSU175,000$8,127,000—
RSU100,000$4,644,000—
RSU75,000$3,483,000—

Per the Outstanding Equity Awards at Fiscal Year-End table in Verona Pharma plc's FY2024 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

31 Form 4 lines since the FY2024 proxy (filed March 18, 2025)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2025-10-07Disposition to the issuer—12,176,144—0
2025-10-07Disposition to the issuer—3,285,280—0
2025-10-07Exercise or conversion—3,285,280—3,285,280
2025-10-07Exercise or conversion derivative—389,792—0
2025-10-07Exercise or conversion derivative—445,536—0
2025-10-07Exercise or conversion derivative—1,649,952—0
2025-10-07Exercise or conversion derivative—800,000—0
2025-10-07Grant or award derivative—1,649,952—1,649,952

The 8 most recent of 31 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Verona Pharma’s named executive officers, FY2024

as the company reported each
Named executive officerRoleFY2024 total
David Zaccardelli · this pagePresident and Chief Executive Officer$19,456,473
Mark HahnChief Financial Officer$19,005,415
Andrew FisherGeneral Counsel$10,821,932
Kathleen RickardChief Medical Officer$7,509,563
Claire PollFormer General Counsel$326,023

The full Verona Pharma compensation record

free company brief

This page is one person within Verona Pharma's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Verona Pharma's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

David Zaccardelli's compensation dossier · One-time report. No refunds.